+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Platelet Aggregation Devices Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • PDF Icon

    Report

  • 142 Pages
  • November 2023
  • Region: Global
  • IMARC Group
  • ID: 5911854

Quick Summary:

As the healthcare sector continues to evolve, the pivotal role of platelet aggregation devices in advancing patient diagnostics and treatment becomes increasingly significant. These devices are not only paramount in the assessment and management of bleeding and cardiovascular disorders but also integral to guiding therapeutic strategies across diverse medical applications. Our comprehensive market research report delves into the expanding realm of platelet aggregation devices, including systems, reagents, consumables, and accessories, and offers indispensable insights to support decision-making within the clinical and research domains.

Balancing the technological advancements with the demand for precision medicine, the report scrutinizes key trends influencing the global market and provides a detailed segmentation analysis by product, type, application, and end-user. Senior executives will find this report a valuable asset in understanding the dynamics of the market, identifying opportunities for growth, and strategically positioning their businesses in the competitive landscape of platelet aggregation devices. With an analytical overview of market trends and a clear forecast path, this report is an essential tool for staying ahead in a rapidly progressing industry.

The global platelet aggregation devices market size reached US$ 525.0 Million in 2022. Looking forward, the market is expected to reach US$ 744.7 Million by 2028, exhibiting a growth rate (CAGR) of 6.00% during 2022-2028.

Platelet aggregation devices comprise adenosine-diphosphate (ADP), thrombin, and ristocetin-induced platelet aggregation (RIPA). These devices are used to diagnose patients with inherited and acquired platelet function disorders, such as excessive bleeding, arterial thrombotic, stroke, and myocardial infarction. They assist in transfusing medicines, pre-surgery tests, and clinical settings to monitor the response of antiplatelet therapies and assess perioperative bleeding risk. At present, due to the launch of new potential biomarkers and technologies, platelet aggregation devices are finding extensive application in personalizing antiplatelet drugs and monitoring the efficacy of various types of pro-hemostatic therapies around the world.

Platelet Aggregation Devices Market Trends

The rising instances of platelet aggregation among patients diagnosed with coronavirus disease (COVID-19) are strengthening the growth of the market. Moreover, due to the growing prevalence of colon cancer, cardiovascular diseases, Kawasaki condition, acute coronary syndrome (ACS), acute ischemic stroke, and acute rheumatic disorders across the globe, there is an increase in the risk of bleeding. This acts as another key factor impelling the growth of the platelet aggregation devices market for clinical management of platelet function disorders. In addition, a significant rise in the aging population suffering from chronic diseases is contributing to the market growth. Apart from this, leading manufacturers are launching novel products to expand their product portfolio and retain a competitive edge in the market. They are also focusing on developing new and simpler point-of-care (POC) diagnostic devices. These devices rely on the latest methodologies for helping in the rapid evaluation of inherited and acquired bleeding disorders and antiplatelet therapies. This, coupled with the increasing need for POC diagnostic devices to fulfill the healthcare demand of the large population, is projected to drive the market.

Key Market Segmentation

This research provides an analysis of the key trends in each sub-segment of the global platelet aggregation devices market report, along with forecasts at the global, regional and country level from 2023-2028. The report has categorized the market based on product, type, application and end user.

Breakup by Product:

  • Systems
  • Reagents
  • Consumables and Accessories

Breakup by Type:

  • Four Channel
  • Dual Channel
  • Eight Channel

Breakup by Application:

  • Clinical Applications
  • Research Applications
  • Cardiovascular Applications
  • Orthopedic Applications

Breakup by End User:

  • Hospitals
  • Diagnostic Laboratories
  • Research and Academic Institutes

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Latin America
  • Brazil
  • Mexico
  • Middle East and Africa

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aggredyne Inc., Chrono-Log Corporation, F. Hoffmann-La Roche AG, Grifols S.A., Hart Biologicals Ltd., Helena Laboratories Corporation, LAbor BioMedical Technologies GmbH, Matis Medical Inc., Sentinel Ch. S.P.A., Siemens AG, Sienco Inc., Sysmex Corporation and WerfenLife SA.

Key Questions Answered in This Report

1. What was the size of the global platelet aggregation devices market in 2022?
2. What is the expected growth rate of the global platelet aggregation devices market during 2023-2028?
3. What has been the impact of COVID-19 on the global platelet aggregation devices market?
4. What are the key factors driving the global platelet aggregation devices market?
5. What is the breakup of the global platelet aggregation devices market based on the product?
6. What is the breakup of the global platelet aggregation devices market based on the type?
7. What is the breakup of the global platelet aggregation devices market based on the application?
8. What is the breakup of the global platelet aggregation devices market based on the end user?
9. What are the key regions in the global platelet aggregation devices market?
10. Who are the key players/companies in the global platelet aggregation devices market?
Frequently Asked Questions about the Global Platelet Aggregation Devices Market

What is the estimated value of the Global Platelet Aggregation Devices Market?

The Global Platelet Aggregation Devices Market was estimated to be valued at $525 Million in 2022.

What is the growth rate of the Global Platelet Aggregation Devices Market?

The growth rate of the Global Platelet Aggregation Devices Market is 6.0%, with an estimated value of $744.7 Million by 2028.

What is the forecasted size of the Global Platelet Aggregation Devices Market?

The Global Platelet Aggregation Devices Market is estimated to be worth $744.7 Million by 2028.

Who are the key companies in the Global Platelet Aggregation Devices Market?

Key companies in the Global Platelet Aggregation Devices Market include ABB Ltd, BAE Systems plc, DNV AS, General Electric Company, Honeywell International Inc., Kongsberg Gruppen, L3Harris Technologies Inc., Mitsui & Co. Ltd., Rolls and Royce plc.

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Platelet Aggregation Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Systems
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Reagents
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Consumables and Accessories
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Type
7.1 Four Channel
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Dual Channel
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Eight Channel
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Application
8.1 Clinical Applications
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Research Applications
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Cardiovascular Applications
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Orthopedic Applications
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Diagnostic Laboratories
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Research and Academic Institutes
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Aggredyne Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Chrono-Log Corporation
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 F. Hoffmann-La Roche AG
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 SWOT Analysis
15.3.4 Grifols S.A.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Hart Biologicals Ltd.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Helena Laboratories Corporation
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 LAbor BioMedical Technologies GmbH
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Matis Medical Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Sentinel Ch. S.P.A.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 Siemens AG
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Sienco Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.12 Sysmex Corporation
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
15.3.13 WerfenLife SA
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio

Companies Mentioned

  • Aggredyne Inc.
  • Chrono-Log Corporation
  • F. Hoffmann-La Roche AG
  • Grifols S.A.
  • Hart Biologicals Ltd.
  • Helena Laboratories Corporation
  • LAbor BioMedical Technologies GmbH
  • Matis Medical Inc.
  • Sentinel Ch. S.P.A.
  • Siemens AG
  • Sienco Inc.
  • Sysmex Corporation
  • WerfenLife SA

Methodology

Loading
LOADING...